Tamarack Advisers’s Pacira BioSciences PCRX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$408K	–	37
2023 Q1	$408K	Sell	10,000 -90,000	-90%	-$3.67M	0.15%	31
2022 Q4	$3.86M	Sell	100,000 -95,000	-49%	-$3.67M	1.99%	14
2022 Q3	$10.4M	Buy	195,000 +20,000	+11%	+$1.06M	6.09%	3
2022 Q2	$10.2M	Sell	175,000 -30,000	-15%	-$1.75M	5.9%	4
2022 Q1	$15.6M	Sell	205,000 -35,000	-15%	-$2.67M	7.4%	2
2021 Q4	$14.4M	Sell	240,000 -135,000	-36%	-$8.12M	5.94%	2
2021 Q3	$21M	Buy	375,000 +15,000	+4%	+$840K	6.63%	4
2021 Q2	$21.8M	Sell	360,000 -190,000	-35%	-$11.5M	6.19%	4
2021 Q1	$38.6M	Sell	550,000 -185,000	-25%	-$13M	7.91%	1
2020 Q4	$43.6M	Buy	735,000 +80,000	+12%	+$4.74M	9.08%	1
2020 Q3	$39.4M	Sell	655,000 -45,000	-6%	-$2.71M	12.14%	1
2020 Q2	$36.7M	Buy	700,000 +150,000	+27%	+$7.87M	10.23%	1
2020 Q1	$18.4M	Sell	550,000 -72,500	-12%	-$2.43M	6.98%	6
2019 Q4	$27.8M	Sell	622,500 -152,500	-20%	-$6.81M	6.35%	5
2019 Q3	$29.5M	Buy	775,000 +150,000	+24%	+$5.71M	7.69%	4
2019 Q2	$27M	Buy	625,000 +305,000	+95%	+$13.2M	8.22%	4
2019 Q1	$12.2M	Buy	+320,000	New	+$12.2M	4.84%	8
2018 Q4	–	Sell	-150,000	Closed	-$7.37M	–	27
2018 Q3	$7.37M	Sell	150,000 -40,000	-21%	-$1.97M	2.11%	18
2018 Q2	$6.09M	Buy	190,000 +71,298	+60%	+$2.29M	2.04%	20
2018 Q1	$3.7M	Sell	118,702 -196,298	-62%	-$6.12M	1.76%	19
2017 Q4	$14.4M	Buy	315,000 +65,000	+26%	+$2.97M	7.85%	3
2017 Q3	$9.39M	Buy	250,000 +35,000	+16%	+$1.31M	5.75%	7
2017 Q2	$10.3M	Sell	215,000 -50,000	-19%	-$2.39M	5.99%	5
2017 Q1	$12.1M	Sell	265,000 -8,000	-3%	-$365K	7.55%	2
2016 Q4	$8.82M	Sell	273,000 -127,000	-32%	-$4.1M	6.24%	5
2016 Q3	$14.2M	Buy	400,000 +210,000	+111%	+$7.44M	4.46%	10
2016 Q2	$6.41M	Buy	+190,000	New	+$6.41M	2.46%	15